Medroxyprogesterone acetate binds the glucocorticoid receptor to stimulate α-ENaC and sgk1 expression in renal collecting duct epithelia

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 2, 2006, Pages

  Thomas, Christie P ^a,b,c   Liu, Kang Z ^a   Vats, Hemender S ^a  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Aldosterone; Epithelial sodium channel; Glucocorticoid response element; Na+ transport

Indexed keywords

11BETA [4 (DIMETHYLAMINO)PHENYL] 4',5' DIHYDRO 6BETA METHYLSPIRO[ESTRA 4,9 DIENE 17BETA,2'(3'H) FURAN] 3 ONE; ALDOSTERONE; ANTIGESTAGEN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; LUCIFERASE; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; MIFEPRISTONE; MINERALOCORTICOID; PROGESTERONE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHANNEL; EPITHELIAL SODIUM CHANNEL; IMMEDIATE EARLY PROTEIN; PROTEIN SERINE THREONINE KINASE; RIBONUCLEASE; SGK PROTEIN;

ADRENALECTOMY; ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TARGETING; KIDNEY CELL; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; REPORTER GENE; SODIUM TRANSPORT; ANIMAL; C57BL MOUSE; DNA FLANKING REGION; DOG; DOSE RESPONSE; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; HUMAN; KIDNEY MEDULLA; METABOLISM;

5' FLANKING REGION; ANIMALS; CELL LINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL SODIUM CHANNEL; HUMANS; IMMEDIATE-EARLY PROTEINS; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY TUBULES, COLLECTING; MALE; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, INBRED C57BL; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GLUCOCORTICOID; RIBONUCLEASES; SODIUM CHANNELS; TRANSFECTION;

EID: 33644859967     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00062.2005     Document Type: Article

References (39)

1. Bamberger CM, Else T, Bamberger AM, Ulrich Beil F, and Schulte HM. Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. J Clin Endocrinol Metab 84: 4055-4061, 1999.
2. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, and McTiernan A. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the women's health initiative randomized trial. JAMA 289: 3243-3253, 2003.
3. Donckier JE, Michel LA, and Buysschaert M. Cushing syndrome and medroxyprogesterone acetate. Lancet 335: 1094, 1990.
4. Funder JW. Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu Rev Med 48: 231-240, 1997.
5. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, and Lifton RP. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289: 119-123, 2000.
6. Harte C, Henry MT, Murphy KD, and Mitchell TH. Progestogens and Cushing's syndrome. Ir J Med Sci 164: 274-275, 1995.
7. Herkert O, Kuhl H, Sandow J, Busse R, and Schini-Kerth VB. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation 104: 2826-2831, 2001.
8. + transport in human lung epithelia is associated with regulated ENaC and sgk1 expression. Am J Physiol Renal Physiol 282: F631-F641, 2002.
9. Itani OA, Liu KZ, Cornish KL, Campbell JR, and Thomas CP. Glucocorticoids stimulate human sgk1 gene expression by activation of a hormone response element in its 5′ flanking region. Am J Physiol Endocrinol Metab 283: E971-E979, 2002.
10. + transport. Am J Physiol Renal Physiol 283: F377-F387, 2002.
11. Kontula K, Andersson LC, Paavonen T, Myllyla G, Teerenhovi L, and Vuopio P. Glucocorticoid receptors and glucocorticoid sensitivity of human leukemic cells. Int J Cancer 26: 177-183, 1980.
12. Koper JW, Molijn GJ, van Uffelen CJ, Stigter E, and Lamberts SW. Antiprogestins and iatrogenic glucocorticoid resistance. Life Sci 60: 617-624, 1997.
13. Koubovec D, Berghe WV, Vermeulen L, Haegeman G, and Hapgood JP. Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells. Mol Cell Endocrinol 221: 75-85, 2004.
14. Learoyd D and McElduff A. Medroxyprogesterone induced Cushing's syndrome. Aust NZ J Med 20: 824-825, 1990.
15. Limbeck GA, Ruvalcaba RH, and Kelley VC. Simulated congenital adrenal hyperplasia in a male neonate associated with medroxyprogesterone therapy during pregnancy. Am J Obstet Gynecol 103: 1169-1170, 1969.
16. Liu W, Wang J, Sauter N, and Pearce D. Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci USA 92: 12480-12484, 1995.
17. Lober J, Mouridsen HT, Salimtschik M, and Johansson E. Pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular route. Acta Obstet Gynecol Scand Suppl 101: 71-74, 1981.
18. Malik KJ, Wakelin K, Dean S, Cove DH, and Wood PJ. Cushing's syndrome and hypothalamic-pituitary adrenal axis suppression induced by medroxyprogesterone acetate. Ann Clin Biochem 33: 187-189, 1996.
19. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, and the Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349: 523-534, 2003.
20. Meneton P, Loffing J, and Warnock DG. Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule. Am J Physiol Renal Physiol 287: F593-F601, 2004.
21. Merrin PK and Alexander WD. Cushing's syndrome induced by medroxyprogesterone. BMJ 301: 345, 1990.
22. Mick VE, Itani OA, Loftus RW, Husted RF, Schmidt TJ, and Thomas CP. The α subunit of the epithelial sodium channel is an aldosterone-induced transcript in mammalian collecting ducts, and this transcriptional response is mediated via distinct cis-elements in the 5′ flanking region of the gene. Mol Endocrinol 15: 575-588, 2001.
23. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, and O'Malley BW. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273: 12101-12108, 1998.
24. Papaleo C, Carella C, Zito GA, Figlia A, Capuano F, and Amato G. ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages. Chemioterapia 3: 220-222, 1984.
25. Pridjian G, Schmit V, and Schreiber J. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells. J Steroid Biochem 26: 313-319, 1987.
26. Sayegh R, Auerbach SD, Li X, Loftus R, Husted R, Stokes JB, and Thomas CP. Glucocorticoid induction of epithelial sodium channel expression in lung and renal epithelia occurs via trans-activation of a hormone response element in the 5′ flanking region of the human epithelial sodium channel α subunit gene. J Biol Chem 274: 12431-12437, 1999.
27. Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, and Thijssen JHH. Classification and pharmacology of progestins. Maturitas 46: 7-16, 2003.
28. Selman PJ, Wolfswinkel J, and Mol JA. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog. Steroids 61: 133-137, 1996.
29. Shotliff K and Nussey SS. Medroxyprogesterone acetate induced Cushing's syndrome. Br J Clin Pharmacol 44: 304, 1997.
30. Siminoski K, Goss P, and Drucker DJ. The Cushing syndrome induced by medroxyprogesterone acetate. Ann Intern Med 111: 758-760, 1989.
31. + homeostasis and hypertension. Endocr Rev 23: 258-275, 2002.
32. Stockand JD. New ideas about aldosterone signaling in epithelia. Am J Physiol Renal Physiol 282: F559-F576, 2002.
33. Szapary D, Xu M, and Simons SS Jr. Induction properties of a transiently transfected glucocorticoid-responsive gene vary with glucocorticoid receptor concentration. J Biol Chem 271: 30576-30582, 1996.
34. Thomas CP and Itani OA. New insights into epithelial sodium channel function in the kidney: site of action, regulation by ubiquitin ligases, serum and glucocorticoid regulated kinase and proteolysis. Curr Opin Nephrol Hypertens 13: 541-548, 2004.
35. + transport regulation in distal kidney nephron cells. Cell Physiol Biochem 13: 21-28, 2003.
36. Wassertheil-Smoller S, Hendrix S, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, and Mysiw WJ. Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative: a randomized trial. JAMA 289: 2673-2684, 2003.
37. Westhoff C. Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety. Contraception 68: 75-87, 2003.
38. + retention in the sgk1-knockout mouse. J Clin Invest 110: 1263-1268, 2002.
39. Zhao Q, Pang J, Favata MF, and Trzaskos JM. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression. Int Immunopharmacol 3: 1803-1817, 2003.